Hellenic consensus on Helicobacter pylori infection

Sotirios D Georgopoulos1, Spyridon Michopoulos2, Theodoros Rokkas3

  • 1Gastroenterology Department, Athens Medical, P. Faliron Hospital (Sotirios D. Georgopoulos).

Insights

Hellenic gastroenterologists developed consensus guidelines for managing Helicobacter pylori (H. pylori) infection. These recommendations aim to standardize H. pylori diagnosis, treatment, and associated disease management in Greece.

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Clinical Microbiology

Background:

  • Helicobacter pylori (H. pylori) infection is a significant global health concern.
  • There was a need for standardized management guidelines for H. pylori within the Hellenic gastroenterology community.
  • Existing international guidelines required adaptation to local epidemiological and clinical contexts.

Purpose of the Study:

  • To establish Hellenic consensus guidelines for the diagnosis and management of Helicobacter pylori infection.
  • To provide a framework for Greek healthcare professionals in clinical practice.
  • To address H. pylori's association with gastric cancer and extragastric disorders.

Main Methods:

  • A consensus meeting was convened by the Hellenic Society of Gastroenterology, involving 41 experts.
  • Participants were divided into four subgroups focusing on H. pylori diagnosis, gastric cancer, extragastric disorders, and treatment.
  • Evidence was reviewed from international and Greek publications, with consensus determined by a 70% acceptance threshold.

Main Results:

  • Consensus was reached on key aspects of H. pylori diagnosis and management.
  • Guidelines were formulated regarding the association of H. pylori with various gastrointestinal and extragastric conditions.
  • Recommendations for H. pylori eradication therapies were established based on graded evidence.

Conclusions:

  • The developed Hellenic consensus guidelines provide a unified approach to H. pylori infection management.
  • These guidelines are expected to improve clinical practice and patient outcomes for H. pylori-related conditions in Greece.
  • The consensus addresses critical areas including diagnosis, treatment, and the link between H. pylori and associated diseases.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
960
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
467
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.0K
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
360
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
680
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.1K